Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Is it ethical to use placebos in osteoporosis trials?
Ragi-Eis S, Zerbini CA, Provenza JR, Griz LH, de Gregório LH, Russo LA, Silva NA, Borges JL, de Souza AC, Castro ML, Lewiecki EM. Ragi-Eis S, et al. J Clin Densitom. 2006 Jul-Sep;9(3):274-80. doi: 10.1016/j.jocd.2006.04.001. J Clin Densitom. 2006. PMID: 16931344
Official Positions for FRAX® Bone Mineral Density and FRAX® simplification from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.
Lewiecki EM, Compston JE, Miller PD, Adachi JD, Adams JE, Leslie WD, Kanis JA, Moayyeri A, Adler RA, Hans DB, Kendler DL, Diez-Perez A, Krieg MA, Masri BK, Lorenc RR, Bauer DC, Blake GM, Josse RG, Clark P, Khan AA; FRAX® Position Development Conference Members. Lewiecki EM, et al. J Clin Densitom. 2011 Jul-Sep;14(3):226-36. doi: 10.1016/j.jocd.2011.05.017. J Clin Densitom. 2011. PMID: 21810530
Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(®). Executive Summary of the 2010 Position Development Conference on Interpretation and use of FRAX® in clinical practice.
Hans DB, Kanis JA, Baim S, Bilezikian JP, Binkley N, Cauley JA, Compston JE, Cooper C, Dawson-Hughes B, El-Hajj Fuleihan G, Leslie WD, Lewiecki EM, Luckey MM, McCloskey EV, Papapoulos SE, Poiana C, Rizzoli R; FRAX(®) Position Development Conference Members. Hans DB, et al. J Clin Densitom. 2011 Jul-Sep;14(3):171-80. doi: 10.1016/j.jocd.2011.05.007. J Clin Densitom. 2011. PMID: 21810521
Official Positions for FRAX(®) clinical regarding glucocorticoids: the impact of the use of glucocorticoids on the estimate by FRAX(®) of the 10 year risk of fracture from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(®).
Leib ES, Saag KG, Adachi JD, Geusens PP, Binkley N, McCloskey EV, Hans DB; FRAX(®) Position Development Conference Members. Leib ES, et al. J Clin Densitom. 2011 Jul-Sep;14(3):212-9. doi: 10.1016/j.jocd.2011.05.014. J Clin Densitom. 2011. PMID: 21810527
Official Positions for FRAX® clinical regarding falls and frailty: can falls and frailty be used in FRAX®? From Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.
Masud T, Binkley N, Boonen S, Hannan MT; FRAX(®) Position Development Conference Members. Masud T, et al. J Clin Densitom. 2011 Jul-Sep;14(3):194-204. doi: 10.1016/j.jocd.2011.05.010. J Clin Densitom. 2011. PMID: 21810525
Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis: bone density, mass, and strength of the radius, and wrist fracture.
Simon JA, Recknor C, Moffett AH Jr, Adachi JD, Franek E, Lewiecki EM, McClung MR, Mautalen CA, Ragi-Eis S, Nicholson GC, Muschitz C, Nuti R, Törring O, Wang A, Libanati C. Simon JA, et al. Among authors: ragi eis s. Menopause. 2013 Feb;20(2):130-7. doi: 10.1097/gme.0b013e318267f909. Menopause. 2013. PMID: 23010883 Clinical Trial.
22 results